XERF in London: How It Works, Evidence, Risks and Cost

XERF is a non-invasive radiofrequency device promoted for skin tightening. This independent guide examines how the technology is described, the current evidence and uncertainties, potential risks, comparisons and market pricing. Volt Cartel does not currently offer XERF, and no launch has been confirmed.

What Is XERF?

XERF (pronounced “zerf”) is a non-invasive monopolar radiofrequency device manufactured by Lutronic. It is marketed in aesthetic practice for concerns such as facial laxity and skin tightening. The technology delivers radiofrequency energy through treatment tips without needles or ablation, but outcomes, recovery and suitability still depend on the protocol and the individual patient.

XERF uses 6.78 MHz and 2 MHz radiofrequency modes. The official FDA 510(k) summary describes both frequencies and non-invasive energy delivery through handpiece tips. Preclinical porcine histology and modelling have reported thermal effects in dermal and subdermal tissues, while a small prospective human study reported short-term improvement in facial laxity. Those findings are encouraging, but they do not prove a surgical-facelift effect or confirm treatment of the SMAS in humans.

How XERF Works

Multifrequency Monopolar RF

Traditional monopolar RF systems commonly operate at a single frequency. XERF can use 6.78 MHz and 2 MHz modes to create different heating patterns. Experimental modelling and porcine studies suggest broader and deeper thermal effects with the lower-frequency mode, but depth varies with the tip, settings, anatomy and protocol. Human tissue-level confirmation of an effect on a specific deep structure such as the SMAS remains limited.

Real-Time Impedance Feedback

The XERF system includes adjustable treatment parameters, tips and modes intended to help a trained operator tailor delivery to the treatment area. Manufacturer materials also describe impedance monitoring and cooling features. These controls support protocol selection, but they do not remove the need for clinical judgement or guarantee a particular result or risk reduction.

What the Evidence Says About Treatment Depth

The SMAS is a fibromuscular layer relevant to facial surgery, but it should not be used as a shorthand promise of facelift-like results. XERF-related porcine histology has reported changes in collagen bundles and fascial layers. A later prospective human study explicitly noted that tissue-level effects on specific deep structures such as the SMAS were not assessed. Clinical claims should therefore distinguish experimental depth findings from proven patient outcomes.

What Areas Can XERF Treat?

XERF is marketed and being studied for facial and neck concerns associated with early to moderate laxity. Areas discussed in provider protocols include:

• Lower face and jawline — addressing jowling and loss of definition along the jaw
• Neck — tightening loose skin and improving neck contour
• Midface — supporting cheek volume and reducing skin descent
• Upper face — softening forehead laxity and brow hooding
• Under-eye area — improving crepiness and skin quality around the eyes

Provider protocols commonly describe a full-face appointment of about 45 minutes, but timing and the use of topical anaesthetic vary. A provider that offers XERF should explain its own protocol during consultation.

Benefits of XERF Skin Tightening

A Non-Invasive Treatment Format

XERF delivers radiofrequency through a surface applicator without microneedles or ablation. Many protocols describe little interruption to normal activities, but that should not be presented as guaranteed minimal downtime. Temporary redness, warmth, tenderness or swelling may still occur.

Designed for Dermal and Subdermal Heating

Preclinical work suggests that the two frequencies can create different thermal patterns in dermal and subdermal tissue. That is a plausible mechanism for collagen remodelling, but it is not evidence that one session reproduces surgical lifting or reliably treats the SMAS in every patient.

Parameters Selected for the Individual

XERF includes impedance feedback and adjustable parameters that can inform treatment delivery. These features do not prove improved outcomes or reduced risk for every patient; the practitioner must still select settings for the area, skin, medical history and treatment objective.

Suitability Across Skin Tones

Radiofrequency does not primarily target melanin in the way many light- and laser-based devices do. That may make RF an option for a wider range of skin tones, but no energy-based procedure is risk-free. Device settings, skin condition, medical history and practitioner assessment still matter, and XERF-specific clinical evidence across all Fitzpatrick types remains limited.

Results That Continue to Develop

Early studies assess changes over the weeks and months after treatment, which is consistent with the expected timescale of collagen remodelling. The size, timing and durability of any visible change vary, and longer-term XERF-specific evidence is still developing.

What to Expect During and After Treatment

The Treatment Itself

Treatment is commonly described as a controlled heating or warming sensation, and some protocols do not use topical anaesthetic. Comfort varies by treatment area, settings and individual sensitivity. The device is non-invasive and does not use microneedles or ablate the skin surface.

Immediately After

Temporary redness, warmth, tenderness or swelling may occur after treatment. Many patients may be able to resume usual activities promptly, but recovery should be described as individual rather than guaranteed to be absent.

Results Timeline

Timeframe	What to Expect
Immediately after	Possible immediate skin firmness; mild warmth or redness
Weeks 1–4	Early collagen remodelling begins; initial tightening visible
Months 1–3	Progressive improvement as new collagen matures
Month 3	Early studies commonly assess outcomes around this point; individual change varies
Month 3–6	Further treatment, if appropriate, depends on the provider protocol and individual response
12 months	Long-term XERF-specific durability is not yet established

How Does XERF Compare to Other Skin Tightening Treatments?

	XERF	Morpheus8	Forma RF	HIFU (Ultherapy)
Technology	Multifrequency monopolar RF	RF microneedling	Bipolar RF	Focused ultrasound
Needles	No	Yes	No	No
Depth reached	Dermal and subdermal heating studied; exact human SMAS effect unconfirmed	Needle depth varies by tip and protocol	Dermis	Focused tissue planes vary by device and protocol
Numbing required	No	Yes	No	Sometimes
Downtime	Commonly minimal; varies	Usually several days; varies	Commonly minimal; varies	Varies by device and protocol
Sessions needed	Early protocols vary	Course varies	Course varies	Course varies
Best for	Studied and marketed for facial laxity	Texture and laxity concerns after assessment	Mild laxity and skin-quality protocols	Laxity concerns after device-specific assessment

XERF and Morpheus8 deliver radiofrequency in different ways. Morpheus8 uses microneedles and is commonly considered where texture, scarring and laxity are being assessed together. XERF uses a non-invasive surface applicator and is marketed for patients exploring a lower-downtime option. The better route depends on the concern, evidence, risk profile and a qualified provider’s assessment.

Who Is a Good Candidate for XERF?

XERF is marketed and has early clinical research for mild to moderate skin laxity, including early jowling, loss of jawline definition and lower-face concerns. A tired or aged appearance can have several causes, so a provider should distinguish skin laxity from volume loss or other factors before recommending treatment.

• Patients in their 30s–50s noticing the first signs of skin descent
• People interested in a non-invasive, commonly lower-downtime option
• People who prefer to avoid microneedles, subject to individual suitability
• People with darker skin tones who have been individually assessed; RF is not melanin-targeting, but settings and risk still require professional judgement
• Patients looking to maintain results after more intensive treatment

XERF is less suitable for patients with significant laxity — those with substantial jowling or neck redundancy are better served by surgical consultation, or by treatments that combine tightening with structural repositioning.

Potential Side Effects

Early studies and provider protocols generally describe temporary treatment effects, and the device does not intentionally break or ablate the skin surface. However, the evidence base is still developing, so comparative risk should not be reduced to a blanket claim that one device is safer than another.

• Redness and warmth — may occur after treatment and is commonly temporary
• Swelling or tenderness — may occur and should be discussed if it is persistent or concerning
• Temporary skin sensitivity — the treated area may feel warm or sensitive for a period after treatment

A provider that offers XERF should explain contraindications, device-specific risks and what to do if an unexpected reaction occurs. Volt Cartel does not currently offer XERF and therefore does not provide XERF treatment planning.

Typical XERF London Market Pricing (Not Volt Cartel Pricing)

Published XERF prices vary by provider, treatment area and protocol. Volt Cartel does not offer XERF and has no XERF price list. Readers should obtain current quotations directly from qualified providers that offer the device.

Why Volt Cartel Is Monitoring XERF

• Current position. Volt Cartel does not currently offer XERF and has not confirmed a launch. We monitor new technologies before deciding whether they belong in the clinic. This article is educational and is not an announcement, price list or invitation to book XERF.

Clinical Review and Evidence Limitations

This article does not present a Volt Cartel doctor’s endorsement of XERF. Evidence for newer devices should be assessed against peer-reviewed studies, the precise regulatory indication, study quality and longer-term follow-up. Claims elsewhere in this guide require formal clinical and editorial review before the article can be considered release-ready.

Frequently Asked Questions

What is XERF?

XERF is a non-invasive monopolar radiofrequency device manufactured by Lutronic. The device uses 6.78 MHz and 2 MHz energy delivered through treatment tips without needles or ablation. The FDA issued a 510(k) substantial-equivalence decision in August 2025; the official indication in that clearance is electrocoagulation and haemostasis in dermatologic and general surgical procedures, not a blanket approval of every aesthetic skin-tightening claim.

How is XERF different from Morpheus8?

Both use radiofrequency energy but via different delivery methods. Morpheus8 is an RF microneedling platform that uses needles to deliver energy at controlled depths. XERF delivers energy non-invasively through a surface applicator. Morpheus8 is commonly used where texture, scarring and laxity are considered together; XERF is marketed for non-invasive tightening. They should not be described as automatically complementary without an individual plan and adequate evidence for the proposed sequence.

How is XERF different from HIFU?

XERF and HIFU use different energy: XERF uses monopolar radiofrequency, while HIFU uses focused ultrasound. Provider and manufacturer materials often describe XERF as comfortable, but robust head-to-head clinical data comparing pain, depth and outcomes with HIFU remain limited. Device, protocol and patient factors all affect the experience.

What does XERF treat?

XERF is marketed in aesthetic practice for concerns such as facial laxity, jowling and neck laxity. Early studies have examined facial tightening outcomes, but claims about exact tissue depth or equivalence to a surgical facelift should be interpreted cautiously. It is not an ablative resurfacing treatment and should not be assumed to address scarring or pigmentation in the same way as RF microneedling or CO₂ laser.

Is XERF painful?

Treatment is commonly described as warmth, and some protocols may not require topical anaesthetic. Comfort varies by settings, treatment area and individual sensitivity. High-quality head-to-head pain data comparing XERF with HIFU remain limited, so a provider should not promise a particular pain experience.

What is the downtime after XERF?

Minimal downtime is commonly described because XERF is non-invasive and non-ablative. Temporary redness, warmth, tenderness or swelling can still occur, and actual recovery varies. It should not be presented as guaranteed minimal downtime or used as a universal comparison with Morpheus8 or CO₂ laser.

How many XERF sessions are needed?

Published studies and provider protocols use different treatment courses. A recent small prospective study used two sessions four weeks apart, while other protocols may vary. The optimal number and interval are still being established, and a provider should tailor any course to the patient and the evidence.

How long do XERF results last?

Long-term durability specific to XERF is not yet established. Collagen remodelling may continue for months after radiofrequency treatment, but maintenance intervals and a one- or two-year duration should not be promised without stronger device-specific follow-up.

Is XERF FDA cleared?

Yes, with an important qualification. The FDA made a 510(k) substantial-equivalence decision for XERF on 11 August 2025. That permits marketing for the stated indication — electrocoagulation and haemostasis — and is not the same as premarket approval or proof of every aesthetic claim. No clinical tests were included in that 510(k) submission.

Is XERF safe for all skin tones?

Radiofrequency does not primarily target melanin, which can make RF relevant when a provider is assessing a wider range of skin tones. That does not make XERF risk-free or prove identical safety across all Fitzpatrick types. Settings, skin condition, medical history and individual assessment remain important, and XERF-specific evidence is still limited.

Does Volt Cartel offer XERF?

No. Volt Cartel does not currently offer XERF, and no launch date has been confirmed. This page is an independent educational guide, not an announcement that the treatment is available or scheduled for launch.

How much does XERF cost in London?

Prices published by other London providers vary by treatment area and protocol. Volt Cartel does not offer XERF and has no XERF price list. Any market figures on this page are informational estimates rather than Volt Cartel prices.

Can XERF be combined with other treatments?

Published evidence and provider protocols may discuss combining energy-based treatments, but suitability depends on timing, skin condition and the treatments involved. Volt Cartel does not plan XERF combinations because it does not offer the device.

Who is not suitable for XERF?

Standard RF contraindications may include pacemakers or implanted electronic devices, metal implants in the treatment area, pregnancy, and active skin infection or open wounds. Suitability and contraindications must be assessed by a qualified provider that offers the device.

Key Takeaways

• XERF uses 6.78 MHz and 2 MHz monopolar RF modes. Preclinical research reports dermal and subdermal thermal effects, but exact human SMAS treatment has not been confirmed.
• The FDA issued a 510(k) substantial-equivalence decision in August 2025. Its stated indication is electrocoagulation and haemostasis; this is not premarket approval of every aesthetic skin-tightening claim.
• Comfort and recovery claims need context. Published protocols and individual recovery reports should be reviewed alongside study quality, treatment settings and patient selection.
• Volt Cartel does not currently offer XERF, has no XERF price list and has not confirmed a launch.
• XERF and Morpheus8 use different delivery methods. Comparisons should be based on the concern being treated, evidence quality, safety and a provider’s individual assessment rather than a promise that the treatments will be combined.

Related Treatments

• Morpheus8 — RF microneedling for skin tightening and texture; best for patients who can tolerate downtime
• Forma RF — gentle bipolar RF for mild laxity and maintenance
• Anti-Wrinkle Injections — relaxes dynamic lines; often combined with skin tightening
• Dermal Fillers — restores lost volume alongside structural tightening
• Polynucleotides — regenerative skin quality treatment; pairs well with tightening procedures

XERF Availability at Volt Cartel Shoreditch

XERF is not currently offered at Volt Cartel Shoreditch and no launch has been confirmed. The clinic address below is provided for general Volt Cartel information, not as an XERF service location.

Ground Floor, 86–90 Paul Street, Shoreditch, London EC2A 4NE

---

Current XERF Availability at Volt Cartel

XERF is not available to book at Volt Cartel, and no launch is confirmed. For an assessment of concerns such as skin laxity, see the treatments and consultations that are currently available.

---

References

1. Alam M, White LE, Martin N, et al. Ultrasound Tightening of Facial and Neck Skin: A Rater-Blinded Prospective Cohort Study. J Am Acad Dermatol. 2010;62(2):262–269. [PubMed]
2. Dierickx CC. The Role of Deep Heating for Non-Invasive Skin Rejuvenation. Lasers Surg Med. 2006;38(9):799–807. [PubMed]
3. Alexiades M, Berube D. Randomized, Blinded, 3-Arm Clinical Trial Assessing Optimal Temperature and Duration for Bipolar Radiofrequency Fractional Resurfacing. Dermatol Surg. 2015;41(4):454–462. [PubMed]
4. Varani J, Dame MK, Rittie L, et al. Decreased Collagen Production in Chronologically Aged Skin. Am J Pathol. 2006;168(6):1861–1868. [PubMed]
5. Fisher GJ, Varani J, Voorhees JJ. Looking Older: Fibroblast Collapse and Therapeutic Implications. Arch Dermatol. 2008;144(5):666–672. [PubMed]
6. U.S. Food and Drug Administration. XERF 510(k) summary K251327, decision dated 11 August 2025. [FDA]
7. Hong J, Ryu HG, et al. Efficacy of dual-frequency noninvasive monopolar radiofrequency in skin tightening: histological evidence. [PubMed Central]
8. Clinical outcomes following dual-frequency noninvasive monopolar radiofrequency treatment for facial laxity and lower-face lifting: a prospective multicentre study. [PubMed Central]

Always consult a qualified medical or aesthetic professional before undergoing any treatment. Individual results vary.

Frequently asked questions